Literature DB >> 22004794

Establishing bioequivalence for orally inhaled drug products.

Peter T Daley-Yates, David A Parkins.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22004794     DOI： 10.1517/17425247.2011.617538

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN： 1742-5247            Impact factor:   6.648


× No keyword cloud information.
  2 in total

1.  Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India.

Authors:  Sau L Lee; Bhawana Saluja; Alfredo García-Arieta; Gustavo Mendes Lima Santos; Ying Li; Sarah Lu; Shuguang Hou; Juliet Rebello; Abhijit Vaidya; Jaideep Gogtay; Shrinivas Purandare; Svetlana Lyapustina
Journal:  AAPS J       Date:  2015-05-23       Impact factor: 4.009

2.  A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products.

Authors:  Gonçalo Farias; Jagdeep Shur; Robert Price; Elizabeth Bielski; Bryan Newman
Journal:  AAPS J       Date:  2021-05-18       Impact factor: 4.009
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.